Similarly, recombinant human chemerin treatment in high-fat diet mice alleviated steatosis and inflammation, improved insulin sensitivity, and decreased ALT/AST levels via CMKLR1-dependent JAK2–STAT3 activation, which enhanced autophagy and reduced oxidative stress [53,54]. The gene discussed is RARRES2; the disease is steatosis.